A Study to Test Bioequivalence Between One Test Formulation of Ibuprofen and Two Reference Treatments

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Pain
Interventions
DRUG

Ibuprofen

A single 2 x 100 mg dose of an experimental Ibuprofen Fast Melt Orodispersible Tablet administered orally, with a 7-day washout between visits

DRUG

Ibuprofen

A single 200 mg Nurofen Meltlets Orodispersible Tablet administered orally, with a 7-day washout between visits

DRUG

Ibuprofen

A single 2 x 100 mg dose of Junior Strength Motrin Chewable Tablet administered orally, with a 7-day washout between visits

Trial Locations (1)

H3P 3P1

Algorithme Pharma Inc., Mount Royal

Sponsors

Lead Sponsor

All Listed Sponsors
lead

McNeil AB

INDUSTRY